I believe that to be true or the Einstein CRO is c
Post# of 151575
Dr. Brunke must believe in Leronlimab or she wouldn't have joined the BOD. High caliber person, we are lucky to have her. Could she move into the CEO spot?
It does look like we are doing a major pivot to either go after NASH or oncology or both but our financial picture has to change. It is like having a new company but not exactly starting from scratch and the drug, how can we forget, is Leronlimab.
Kind of like li'l tormented John Barley Corn - will prove the strongest man at last!

